臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"guo j c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 123 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-15T01:09:06Z	Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors	Guo J.-C.; Chia-Chi Lin; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏	2022-09-15T01:08:47Z	Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites	Guo J.-C.; Lin C.-Y.; Chia-Chi Lin; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏	2022-09-15T01:08:43Z	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Chia-Chi Lin; Chen Y.-J.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-08-19T06:48:44Z	Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites	Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏	2022-08-19T00:20:42Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	CHIUN HSU; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.; Guo J.-C.; Kuo T.-C.; Wu H.; Yang S.-H.
臺大學術典藏	2022-08-19T00:20:36Z	Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients	Yeh K.-H.; Cheng A.-L.; Tien Y.-W.; Kuo S.-H.; CHIUN HSU; Yang S.-H.; Guo J.-C.
臺大學術典藏	2022-05-24T06:10:26Z	NaP1 zeolite membranes with high selectivity for water-alcohol pervaporation	Guo J.-C.;Zou C.;Chiang C.-Y.;Chang T.-A.;Chen J.-J.;Lin L.-C.;Kang D.-Y.; Guo J.-C.; Zou C.; Chiang C.-Y.; Chang T.-A.; Chen J.-J.; Lin L.-C.; Kang D.-Y.; LI-CHIANG LIN
臺大學術典藏	2022-05-05T08:48:52Z	Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy	Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; CHIA-CHUN WANG; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M.
臺大學術典藏	2022-03-22T08:29:11Z	NaP1 zeolite membranes with high selectivity for water-alcohol pervaporation	Guo J.-C;Zou C;Chiang C.-Y;Chang T.-A;Chen J.-J;Lin L.-C;Kang D.-Y.; Guo J.-C; Zou C; Chiang C.-Y; Chang T.-A; Chen J.-J; Lin L.-C; Kang D.-Y.; DUN-YEN KANG
臺大學術典藏	2022-03-22T08:29:11Z	NaP1 zeolite membranes with high selectivity for water-alcohol pervaporation	Guo J.-C;Zou C;Chiang C.-Y;Chang T.-A;Chen J.-J;Lin L.-C;Kang D.-Y.; Guo J.-C; Zou C; Chiang C.-Y; Chang T.-A; Chen J.-J; Lin L.-C; Kang D.-Y.; DUN-YEN KANG
臺大學術典藏	2022-03-22T08:26:20Z	NaP1 zeolite membranes with high selectivity for water-alcohol pervaporation	Guo J.-C;Zou C;Chiang C.-Y;Chang T.-A;Chen J.-J;Lin L.-C;Kang D.-Y.; Guo J.-C; Zou C; Chiang C.-Y; Chang T.-A; Chen J.-J; Lin L.-C; Kang D.-Y.; DUN-YEN KANG
臺大學術典藏	2022-03-15T03:29:02Z	Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites	Guo J.-C.; Lin C.-Y.; Lin C.-C.; TA-CHEN HUANG; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; Hsu C.-H.
臺大學術典藏	2022-03-15T03:29:02Z	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	TA-CHEN HUANG; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏	2022-03-08T03:44:06Z	Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: A retrospective study	Guo J.-C.; SHIH-HUNG YANG
臺大學術典藏	2022-03-08T03:44:05Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:04Z	Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy	SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-08T03:44:04Z	Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer	SHIH-HUNG YANG; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:03Z	Postoperative imaging and tumor marker surveillance in resected pancreatic cancer	Wu H.; Guo J.-C.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H.
臺大學術典藏	2022-03-08T03:44:02Z	Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients	SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-02-21T02:04:36Z	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2022-02-07T03:29:06Z	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏	2022-02-07T03:29:04Z	Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites	Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏	2022	Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancer	Kuo H.-Y.; Guo J.-C.; CHIH-HUNG HSU
臺大學術典藏	2022	Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy	Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏	2022	B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma	Hsu C.-L.; Huang Y.-L.; Lin C.-C.; Huang T.-C.; Wu I.-C.; Lin C.-Y.; Lien M.-Y.; Kuo H.-Y.; Cheng A.-L.; CHIH-HUNG HSU; Guo J.-C.

Showing items 1-25 of 123 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2816861
	???header.visitor??? : 27625478 ???header.onlineuser??? : 596 ???header.sponsordeclaration???